Gastrointestinal Stromal Tumor (GIST) is a rare disease, but it should not be overlooked.

Image

Share


Gastrointestinal Stromal Tumor (GIST) is a rare disease, but it should not be overlooked.

Chronic abdominal pain, black stools, or bleeding in the stomach—many people may think these are just common gastritis symptoms, but in some cases, they may be signs of a rare disease called Gastrointestinal Stromal Tumor (GIST).

 

Although GIST tumors occur in only about 11–15 people per 1 million population per year, the importance of this disease lies in “early diagnosis and appropriate treatment planning” because treatment outcomes vary significantly depending on tumor size, location, and risk of recurrence.

 

This article will help you understand the causes, symptoms, diagnostic methods, and modern treatment approaches so you can confidently manage this disease.

 

What is GIST?

GIST stands for gastrointestinal stromal tumor. It is a tumor that arises from the autonomic nervous system cells that control the contraction of the gastrointestinal tract. It is a rare tumor, occurring in about 11-15 people per 1 million population.

 

How does GIST develop?

GIST develops from mutations in the tyrosine kinase receptor, which controls cell division, causing uncontrolled cell proliferation.

 

What are the symptoms of GIST?

Most GIST tumors are found in the stomach (80%) but can occur anywhere along the gastrointestinal tract. Therefore, symptoms usually arise from the stomach, such as bleeding, abdominal pain, black stools, vomiting, or a palpable mass in the abdomen.

 

What screening methods are available?

Since tumors usually cause symptoms only when they are large, small asymptomatic tumors are often detected through gastrointestinal endoscopy.

 

What treatment options are available?

The aggressiveness of GIST depends on the size, location, cell division rate, and gene mutation site. Tumors smaller than 2 cm in the stomach can be managed with symptom monitoring because the risk of spread or progression is low. For tumors larger than 2 cm, complete surgical removal is the only curative treatment.

 

What types of surgery are available?

  1. Open surgery
  2. Laparoscopic surgery Both surgical methods aim to completely remove the tumor. Current research, including studies conducted by the author on Japanese patients in 2015 and Thai patients in 2021, shows equivalent outcomes for both methods. The advantage of laparoscopic surgery is faster recovery and less postoperative pain compared to open surgery.

 

What are the treatment options if the tumor is large and inoperable?

If the tumor is too large to be completely removed surgically, or if surgery involves removing invaded organs with high surgical risk, or if the tumor has metastasized to other organs such as the liver or lungs, targeted therapy with tyrosine kinase inhibitors can help reduce tumor size. Most GISTs respond well to these drugs, shrinking the tumor enough to allow safe surgery later.

 

 

What is the follow-up care after complete tumor removal?

For low-risk cases, such as small tumors with low cell division rates, follow-up includes monitoring with endoscopy or CT scans.

 

For cases with a higher risk of recurrence, adjuvant targeted therapy with tyrosine kinase inhibitors like imatinib for at least 3 years can significantly reduce recurrence risk.

 

What are the treatment outcomes after surgery?

Studies in both Thai and Japanese patients show a 5-year survival rate of over 80%. Factors affecting outcomes include tumor size, cell division rate, and tumor rupture before or during surgery. Early diagnosis improves treatment outcomes.

 

 

The most important thing is “not to overlook abnormal gastrointestinal symptoms.” If you have chronic abdominal pain, bleeding, black stools, or a palpable mass, you should see a specialist for diagnosis to increase the chance of cure and reduce long-term recurrence risk.

 

At Phyathai 2 Hospital, we have a specialized surgical team experienced in laparoscopic surgery of the stomach and gastrointestinal tract, providing comprehensive care for patients with gastrointestinal tumors—from endoscopic diagnosis, CT scan staging, to planning both open and laparoscopic surgeries, as well as considering targeted therapy when appropriate.

 

GIST patient care does not end with surgery but includes individual risk assessment, long-term follow-up, nutritional advice, and rehabilitation to help patients return to life with confidence.

 

Assoc. Prof. Dr. Wisit Kasetsirimawiriya

Specialist in Advanced Minimally Invasive Surgery

Surgical Center, Phyathai 2 Hospital

Loading...

Share


Loading...
Loading...